Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer

Lindor Qunaj, Michael S. May, Alfred I. Neugut, Benjamin O. Herzberg

Open source

DOI
10.3389/fonc.2023.1252516
Published
2023-09-15
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1252516,
  title = {Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer},
  author = {Lindor Qunaj and Michael S. May and Alfred I. Neugut and Benjamin O. Herzberg},
  year = {2023},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2023.1252516},
  url = {https://doi.org/10.3389/fonc.2023.1252516}
}

RIS

TY  - JOUR
TI  - Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
AU  - Lindor Qunaj
AU  - Michael S. May
AU  - Alfred I. Neugut
AU  - Benjamin O. Herzberg
PY  - 2023
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2023.1252516
UR  - https://doi.org/10.3389/fonc.2023.1252516
ER  - 

APA

Qunaj, L., May, M. S., Neugut, A. I., & Herzberg, B. O. (2023). Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1252516

Source records